Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis

J Cyst Fibros. 2022 Mar;21(2):227-229. doi: 10.1016/j.jcf.2021.07.017. Epub 2021 Aug 9.
No abstract available

Keywords: CFTR modulator; Cystic fibrosis; Liver transplantation.

Publication types

  • Case Reports

MeSH terms

  • Aminophenols / adverse effects
  • Benzodioxoles / adverse effects
  • Chloride Channel Agonists / adverse effects
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / diagnosis
  • Cystic Fibrosis* / drug therapy
  • Drug Combinations
  • Humans
  • Indoles
  • Liver Transplantation*
  • Pyrazoles
  • Pyridines
  • Pyrrolidines
  • Quinolones

Substances

  • Aminophenols
  • Benzodioxoles
  • Chloride Channel Agonists
  • Drug Combinations
  • Indoles
  • Pyrazoles
  • Pyridines
  • Pyrrolidines
  • Quinolones
  • tezacaftor
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • ivacaftor
  • elexacaftor